Know Cancer

or
forgot password

    • cancer clinical trials in fullerton, CA

    • Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Virginia K. Crosson Cancer Center at St. Jude Medical Center
    Fullerton, California 92835
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Virginia K. Crosson Cancer Center at St. Jude Medical Center
    Fullerton, California 92835
    Endometrial Cancer
    Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer
    Virginia K. Crosson Cancer Center
    Fullerton, California 92835
    Colorectal Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Saint Jude Medical Center
    Fullerton, California 92835
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    St. Jude Heritage Med Group
    Fullerton, California 92835
    Non-Small Cell Lung Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Saint Jude Medical Center
    Fullerton, California 92835
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Virginia K. Crosson Cancer Center at St. Jude Medical Center
    Fullerton, California 92835
    Head and Neck Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Saint Jude Medical Center
    Fullerton, California 92835
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Saint Jude Medical Center
    Fullerton, California 92835
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Saint Jude Medical Center
    Fullerton, California 92835
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Virginia K. Crosson Cancer Center at St. Jude Medical Center
    Fullerton, California 92835
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    St. Jude Hertiage Medical Group
    Fullerton, California 92835
    Breast Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Virginia K. Crosson Cancer Center at St. Jude Medical Center
    Fullerton, California 92835
    Leukemia
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Saint Jude Medical Center
    Fullerton, California 92835
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery
    St. Jude Heritage Medical Group at Virginia K. Crosson Cancer Center
    Fullerton, California 92835
    Breast Cancer
    Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
    1199.14.1164 Boehringer Ingelheim Investigational Site
    Fullerton, California
    Carcinoma, Non-Small-Cell Lung
    Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
    St. Jude Heritage Medical Group Virginia Crosson Cancer Center
    Fullerton, California 92835
    Breast Cancer
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Saint Jude Medical Center
    Fullerton, California 92835
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
    Location# 044
    Fullerton, California 92835
    Metastatic Colorectal Cancer
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    St. Jude Heritage Healthcare
    Fullerton, California 92835
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
    St. Jude Heritage Medical Group at Virginia K. Crosson Cancer Center
    Fullerton, California 92835
    Esophageal Cancer, Gastric Cancer
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Virginia K. Crosson Cancer Center at St. Jude Medical Center
    Fullerton, California 92835
    Colorectal Cancer, Precancerous Condition
    Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation
    St. Jude Heritage Medical Group Virginia Crosson Cancer Center
    Fullerton, California 92835
    Relapsed or Refractory Multiple Myeloma
    PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
    St. Jude Heritage Healthcare
    Fullerton, California 92835
    Breast Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    Virginia K. Crosson Cancer Center
    Fullerton, California 92835
    Multiple Myeloma
    LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
    1200.75.10112 Boehringer Ingelheim Investigational Site
    Fullerton, California
    Breast Neoplasms
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Virginia K. Crosson Cancer Center at St. Jude Medical Center
    Fullerton, California 92835
    Colorectal Cancer
    CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
    St. Jude Heritage Medical Group Virginia Crosson Cancer Center
    Fullerton, California 92835
    Chronic Myelogenous Leukemia in Chronic Phase
    Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
    TORI FULLERTON (St. Jude Heritage Healthcare Virginia K. Crosson Cancer Center)
    Fullerton, California 92835
    Acinar Cell Carcinoma of Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Pancreatic Carcinoma Recurrent, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Pancreatic Carcinoma Stage III
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Saint Jude Medical Center
    Fullerton, California 92835
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
    St. Jude Medical Center
    Fullerton, California 92835
    Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma, Marginal Zone Lymphoma
    A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
    St. Jude Heritage Medical Group St Jude
    Fullerton, California 92835
    Solid Tumors and Advanced Endometrial Cancer, Endometrial Cancer, Second-line Treatment, VEGF
    Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
    St. Jude Heritage Medical Group
    Fullerton, California 92835
    Follicular Lymphoma
    Efficacy and Safety Study of NeuVax(TM)(Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
    St. Jude Medical Center, Virginia K. Crosson Cancer Center
    Fullerton, California 92801
    HER2 Negative Breast Cancer
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Saint Jude Heritage Healthcare
    Fullerton, California
    Colorectal Cancer
    Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
    St. Jude Heritage Healthcare
    Fullerton, California 92835
    Metastatic Colorectal Cancer, Colorectal Cancer
    Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
    St. Jude Heritage Healthcare, Virginia K. Crosson Cancer Center
    Fullerton, California 92835
    Metastatic Breast Cancer
    Irinotecan in Treating Patients With Esophageal or Stomach Cancer
    St Jude Heritage Health Foundation
    Fullerton, California 92835
    Esophageal Cancer, Gastric Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Crosson Cancer Center at St. Jude Medical Center
    Fullerton, California 92835
    Breast Cancer
    Clinical Trial for Ovarian Cancer (OvaRex®)
    St. Jude Medical Center
    Fullerton, California 92835
    Ovarian Cancer
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Virginia K. Crosson Cancer Center
    Fullerton, California 92835
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    Virginia K. Crosson Cancer Center
    Fullerton, California 92835
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Virginia K. Crosson Cancer Center at St. Jude Medical Center
    Fullerton, California 92835
    Pancreatic Cancer
    A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)
    Virginia K. Crosson Cancer Center (TORI)
    Fullerton, California 92835
    Non-Small-Cell Lung Carcinoma, Neoplasm Recurrence, Local
    Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
    Virginia K. Crosson Cancer Center
    Fullerton, California 92835
    Prostate Cancer
    Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
    Virginia K. Crosson Cancer Center
    Fullerton, California 92835
    Prostate Cancer
    Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC
    Virginia K. Crosson Cancer Center
    Fullerton, California 92835
    Carcinoma, Non-Small-Cell Lung
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Saint Jude Medical Center
    Fullerton, California 92835
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    St. Jude Heritage Medical Group
    Fullerton, California 92835
    Non-Hodgkin's Lymphoma
    Study of EC145 in Patients With Advanced Ovarian and Endometrial Cancers
    St. Jude Heritage Healthcare
    Fullerton, California 92835
    Ovarian Cancer, Endometrial Cancer
    Cognition in the Study of Tamoxifen and Raloxifene
    Virginia K. Crosson Cancer Center
    Fullerton, California 92835
    Cognition, Aging
    Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy
    Investigational Site Number 840072
    Fullerton, California 92835
    Venous Thromboembolism, Cancer
    Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
    St. Jude Heritage Healthcare
    Fullerton, California 92835
    Myelodysplastic Syndrome (MDS)
    Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer
    St. Jude Heritage Healthcare
    Fullerton, California 92835
    Non-small Cell Lung Cancer
    Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
    St. Jude Heritage Medical Group
    Fullerton, California 92835
    Colorectal Cancer, Neoplasms, Colorectal
    Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
    Saint Jude Heritage Medical Center
    Fullerton, California 92835
    Anemia, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small-Cell Lung, Bladder Cancer, Cancer of Head and Neck, Uterine Cervical Cancer